Morgan Stanley Remains Sidelined on Johnson & Johnson (JNJ) Following Reuters Article
Tweet Send to a Friend
Morgan Stanley analyst, David Lewis, reiterated an Equalweight rating and $153.00 price target on Johnson & Johnson (NYSE: JNJ) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
